Loading candles…
Tatva Chintan Pharma Chem Limited was incorporated in 1996 by first-generation technocrat entrepreneurs. The company operates in the pharmaceuticals, agrochemicals, and energy storage industries. It specializes in manufacturing specialty chemicals, including structure directing agents, phase transfer catalysts, electrolyte salts for batteries, pharmaceutical intermediates, and agrochemical intermediates. Tatva Chintan engages in the entire value chain from research and development to manufacturing and global distribution, with a presence in India and worldwide markets. It focuses on complex chemical processes such as conventional synthesis, electrolysis, and continuous flow chemistry. The company holds a notable market position as a leading manufacturer of phase transfer catalysts and structure directing agents.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend, if any. | 16 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 21 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 24 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend, if any. | 2 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.